Beverly-based incubator chosen as only international soft landings center in New England; Offers specialized services to foreign biotech and cleantech companies establishing US operations North Shore InnoVentures (NSIV) earned recognition as part of the global Soft Landings Network by the International Business Innovation Association (InBIA). NSIV is the only location in New England to joinRead more
Blog
For patients dealing with anxiety, depression, phobia, and other behavioral illnesses, even going out to see a therapist face-to-face can be a real barrier to treatment. iHope Network recognizes this: multiple studies find no-show rates of 10-30% at a typical brick-and-mortar practice, while a recent check of iHope’s online appointments found only 28 no-shows outRead more
HepatoChem was founded as a company for metabolite production, hence the name — “Hepato” refers to the liver, which is the organ responsible for most of metabolism. The company provides a sort “chemical liver” for biotech and pharma companies by processing drugs in the same way that they would be processed in the human body.Read more
Once again, interns working at NSIV impressed us with all they accomplished, both for their companies and personally. At the August InnoVentures U, our summer interns made formal presentations before a group of 30, explaining what kind of projects they were engaged in and the impact of their work. Great prep for being able toRead more
New NSIV CEO & President, Chris Ilsley (say “ills lee”) has been with us for just over a month. We briefly introduced him to you in last month’s newsletter, but now it’s time for a bit more in-depth look. To help us get acquainted, he recently sat down for a Q&A. Find out about hisRead more
This month, we welcome back Glycologix, who recently rejoined NSIV. At Glycologix, what began as a potential cure for wrinkles has evolved into what could become the first treatment on the market for a debilitating urology disease. The company is developing a compound that mimics the properties of proteogylcans, molecules which provide hydration and performRead more
NSIV member company, InsomniSolv, recently won Sanofi’s VivaTech 2018 “Sleep Challenge”, voted the winner over 21 other submissions. Founder, Peter Kelley, is developing a neurostimulator device to mitigate insomnia. Read about the “Sleep Challenge” and watch a short video about InsomniSolv here.Read more
Every year, $100 billion goes into standard cancer treatment, prescribed based on the cancer’s stage and tissue of origin. Patients receiving these treatments assume that they are being given the medicine they need, but the reality is inauspicious — every cancer is unique, and only 1 out of 4 standard treatments will actually prolong life.Read more
CrowdComfort CrowdComfort started as a simple idea, pitched at the 2013 Boston Cleanweb Hackathon: what if people could use their smartphones to unlock efficiencies in building and workplace management? Since these humble beginnings, CrowdComfort has come a long way. With the help of Boston’s wonderful cleantech community, it launched the world’s first Human Sensor Network™Read more
NSIV is thrilled to share the wonderful news that we are receiving a grant from the Cummings Foundation’s new Sustaining Grants Program. The grant will provide NSIV with an annual installment of $20,000 for ten years. Winner of an earlier multi-year grant of $100,000 in 2013, NSIV received the final distribution in 2017 and became eligibleRead more